180 related articles for article (PubMed ID: 38114477)
21. Cell-free DNA 5-hydroxymethylcytosine profiles of long non-coding RNA genes enable early detection and progression monitoring of human cancers.
Zhou M; Hou P; Yan C; Chen L; Li K; Wang Y; Zhao J; Su J; Sun J
Clin Epigenetics; 2021 Oct; 13(1):197. PubMed ID: 34689838
[TBL] [Abstract][Full Text] [Related]
22. 5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic and predictive biomarkers for coronary artery disease.
Dong C; Chen J; Zheng J; Liang Y; Yu T; Liu Y; Gao F; Long J; Chen H; Zhu Q; He Z; Hu S; He C; Lin J; Tang Y; Zhu H
Clin Epigenetics; 2020 Jan; 12(1):17. PubMed ID: 31964422
[TBL] [Abstract][Full Text] [Related]
23. Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma.
Wang WT; Guo CQ; Cui GH; Zhao S
World J Gastroenterol; 2019 Oct; 25(37):5604-5618. PubMed ID: 31602161
[TBL] [Abstract][Full Text] [Related]
24. 5-Hydroxymethylcytosine Signatures in Circulating Cell-Free DNA as Diagnostic Biomarkers for Late-Onset Alzheimer's Disease.
Chen L; Shen Q; Xu S; Yu H; Pei S; Zhang Y; He X; Wang Q; Li D
J Alzheimers Dis; 2022; 85(2):573-585. PubMed ID: 34864677
[TBL] [Abstract][Full Text] [Related]
25. Sensitive detection of stage I lung adenocarcinoma using plasma cell-free DNA breakpoint motif profiling.
Guo W; Chen X; Liu R; Liang N; Ma Q; Bao H; Xu X; Wu X; Yang S; Shao Y; Tan F; Xue Q; Gao S; He J
EBioMedicine; 2022 Jul; 81():104131. PubMed ID: 35780566
[TBL] [Abstract][Full Text] [Related]
26. Tissue protein biomarker candidates to predict progression of esophageal squamous cell carcinoma and precancerous lesions.
Wang M; Smith JS; Wei WQ
Ann N Y Acad Sci; 2018 Dec; 1434(1):59-69. PubMed ID: 29882970
[TBL] [Abstract][Full Text] [Related]
27. Genome-wide methylation profiling identified methylated KCNA3 and OTOP2 as promising diagnostic markers for esophageal squamous cell carcinoma.
Bian Y; Gao Y; Lu C; Tian B; Xin L; Lin H; Zhang Y; Zhang X; Zhou S; Wan K; Zhou J; Li Z; Chen H; Wang L
Chin Med J (Engl); 2023 Aug; ():. PubMed ID: 37650127
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-155 acts as a diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma.
Zheng YJ; Liang TS; Wang J; Zhao JY; Zhai SN; Yang DK; Wang LD
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):977-982. PubMed ID: 32573268
[TBL] [Abstract][Full Text] [Related]
29. Autoantibodies against tumor-associated antigens combined with microRNAs in detecting esophageal squamous cell carcinoma.
Sun G; Ye H; Wang X; Li T; Jiang D; Qiu C; Dai L; Shi J; Wang K; Song C; Wang P; Zhang J
Cancer Med; 2020 Feb; 9(3):1173-1182. PubMed ID: 31856412
[TBL] [Abstract][Full Text] [Related]
30. Integrated epigenetic biomarkers in circulating cell-free DNA as a robust classifier for pancreatic cancer.
Cao F; Wei A; Hu X; He Y; Zhang J; Xia L; Tu K; Yuan J; Guo Z; Liu H; Xie D; Li A
Clin Epigenetics; 2020 Jul; 12(1):112. PubMed ID: 32703318
[TBL] [Abstract][Full Text] [Related]
31. 5hmC-MIQuant: Ultrasensitive Quantitative Detection of 5-Hydroxymethylcytosine in Low-Input Cell-Free DNA Samples.
Yuan F; Yu Y; Zhou YL; Zhang XX
Anal Chem; 2020 Jan; 92(1):1605-1610. PubMed ID: 31829563
[TBL] [Abstract][Full Text] [Related]
32. Blood-based biomarkers for early detection of esophageal squamous cell carcinoma.
Chu LY; Peng YH; Weng XF; Xie JJ; Xu YW
World J Gastroenterol; 2020 Apr; 26(15):1708-1725. PubMed ID: 32351288
[TBL] [Abstract][Full Text] [Related]
33. 5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers.
Li W; Zhang X; Lu X; You L; Song Y; Luo Z; Zhang J; Nie J; Zheng W; Xu D; Wang Y; Dong Y; Yu S; Hong J; Shi J; Hao H; Luo F; Hua L; Wang P; Qian X; Yuan F; Wei L; Cui M; Zhang T; Liao Q; Dai M; Liu Z; Chen G; Meckel K; Adhikari S; Jia G; Bissonnette MB; Zhang X; Zhao Y; Zhang W; He C; Liu J
Cell Res; 2017 Oct; 27(10):1243-1257. PubMed ID: 28925386
[TBL] [Abstract][Full Text] [Related]
34. Feasibility of using P16 methylation as a cytologic marker for esophageal squamous cell carcinoma screening: A pilot study.
Fan Z; Qin Y; Zhou J; Chen R; Gu J; Li M; Zhou J; Li X; Lin D; Wang J; Deng D; Wei W
Cancer Med; 2022 Nov; 11(21):4033-4042. PubMed ID: 35352503
[TBL] [Abstract][Full Text] [Related]
35. Cell-Free DNA 5-Hydroxymethylcytosine Signatures for Lung Cancer Prognosis.
Shao J; Olsen RJ; Kasparian S; He C; Bernicker EH; Li Z
Cells; 2024 Feb; 13(4):. PubMed ID: 38391911
[TBL] [Abstract][Full Text] [Related]
36. Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study.
Szymanski JJ; Sundby RT; Jones PA; Srihari D; Earland N; Harris PK; Feng W; Qaium F; Lei H; Roberts D; Landeau M; Bell J; Huang Y; Hoffman L; Spencer M; Spraker MB; Ding L; Widemann BC; Shern JF; Hirbe AC; Chaudhuri AA
PLoS Med; 2021 Aug; 18(8):e1003734. PubMed ID: 34464388
[TBL] [Abstract][Full Text] [Related]
37. Integrated fragmentomic profile and 5-Hydroxymethylcytosine of capture-based low-pass sequencing data enables pan-cancer detection via cfDNA.
Zhang Z; Pi X; Gao C; Zhang J; Xia L; Yan X; Hu X; Yan Z; Zhang S; Wei A; Guo Y; Liu J; Li A; Liu X; Zhang W; Liu Y; Xie D
Transl Oncol; 2023 Aug; 34():101694. PubMed ID: 37209526
[TBL] [Abstract][Full Text] [Related]
38. Hypomethylation in HBV integration regions aids non-invasive surveillance to hepatocellular carcinoma by low-pass genome-wide bisulfite sequencing.
Zhang H; Dong P; Guo S; Tao C; Chen W; Zhao W; Wang J; Cheung R; Villanueva A; Fan J; Ding H; Schrodi SJ; Zhang D; Zeng C
BMC Med; 2020 Aug; 18(1):200. PubMed ID: 32741373
[TBL] [Abstract][Full Text] [Related]
39. Alterations of 5-hydroxymethylcytosines in circulating cell-free DNA reflect retinopathy in type 2 diabetes.
Han L; Chen C; Lu X; Song Y; Zhang Z; Zeng C; Chiu R; Li L; Xu M; He C; Zhang W; Duan S
Genomics; 2021 Jan; 113(1 Pt 1):79-87. PubMed ID: 33221518
[TBL] [Abstract][Full Text] [Related]
40. Aberrant DNA methylation of PAX1, SOX1 and ZNF582 genes as potential biomarkers for esophageal squamous cell carcinoma.
Tang L; Liou YL; Wan ZR; Tang J; Zhou Y; Zhuang W; Wang G
Biomed Pharmacother; 2019 Dec; 120():109488. PubMed ID: 31629253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
